Campbell & CO Investment Adviser LLC Takes Position in Core Laboratories Inc. $CLB

Campbell & CO Investment Adviser LLC acquired a new position in shares of Core Laboratories Inc. (NYSE:CLB) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 25,831 shares of the oil and gas company’s stock, valued at approximately $298,000. Campbell & CO Investment Adviser LLC owned about 0.06% of Core Laboratories as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Fox Run Management L.L.C. purchased a new stake in Core Laboratories during the second quarter valued at about $202,000. Moors & Cabot Inc. increased its position in shares of Core Laboratories by 5.3% during the 2nd quarter. Moors & Cabot Inc. now owns 73,954 shares of the oil and gas company’s stock valued at $852,000 after purchasing an additional 3,695 shares during the last quarter. Assetmark Inc. increased its position in shares of Core Laboratories by 160.8% during the 2nd quarter. Assetmark Inc. now owns 7,530 shares of the oil and gas company’s stock valued at $87,000 after purchasing an additional 4,643 shares during the last quarter. Arkadios Wealth Advisors purchased a new position in shares of Core Laboratories during the 2nd quarter valued at about $978,000. Finally, Envestnet Asset Management Inc. lifted its position in Core Laboratories by 11.4% in the 2nd quarter. Envestnet Asset Management Inc. now owns 282,871 shares of the oil and gas company’s stock worth $3,259,000 after buying an additional 28,866 shares during the last quarter. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on CLB. Wall Street Zen upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, July 26th. Zacks Research raised shares of Core Laboratories from a “strong sell” rating to a “hold” rating in a research note on Friday, August 15th. Finally, Weiss Ratings upgraded shares of Core Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 24th. Four analysts have rated the stock with a Hold rating, According to MarketBeat.com, Core Laboratories has a consensus rating of “Hold” and a consensus target price of $12.50.

Core Laboratories Price Performance

CLB stock opened at $15.08 on Tuesday. The stock has a market capitalization of $702.17 million, a price-to-earnings ratio of 22.51, a PEG ratio of 8.28 and a beta of 1.40. The firm’s 50-day moving average price is $13.47 and its two-hundred day moving average price is $12.24. The company has a current ratio of 2.37, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. Core Laboratories Inc. has a 12-month low of $9.72 and a 12-month high of $21.76.

Core Laboratories (NYSE:CLB) last posted its earnings results on Wednesday, October 22nd. The oil and gas company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.03. Core Laboratories had a return on equity of 12.85% and a net margin of 6.21%.The company had revenue of $134.52 million for the quarter, compared to analysts’ expectations of $130.92 million. During the same period last year, the firm earned $0.25 earnings per share. Core Laboratories’s quarterly revenue was up .1% on a year-over-year basis. Core Laboratories has set its Q4 2025 guidance at 0.180-0.22 EPS. As a group, equities analysts predict that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Core Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 24th. Stockholders of record on Monday, November 3rd will be paid a dividend of $0.01 per share. The ex-dividend date of this dividend is Monday, November 3rd. This represents a $0.04 annualized dividend and a dividend yield of 0.3%. Core Laboratories’s payout ratio is 5.97%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.